Edition:
India

St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

78.01USD
26 Aug 2016
Change (% chg)

$0.19 (+0.24%)
Prev Close
$77.82
Open
$77.71
Day's High
$78.15
Day's Low
$75.34
Volume
1,830,570
Avg. Vol
954,309
52-wk High
$84.00
52-wk Low
$48.83

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement... (more)

Overall

Beta: 1.32
Market Cap(Mil.): $22,227.34
Shares Outstanding(Mil.): 284.93
Dividend: 0.31
Yield (%): 1.59

Financials

RPT-Whiplashed investors stay skittish about St. Jude

Aug 26 One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.

27 Aug 2016

St. Jude says report by short sellers 'false and misleading'

Medical device manufacturer St. Jude Medical Inc said on Friday a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading."

27 Aug 2016

Whiplashed investors stay skittish about St. Jude

One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation agains

27 Aug 2016

Whiplashed investors stay skittish about St. Jude

Aug 26 One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.

27 Aug 2016

Muddy Waters says St. Jude shares could fall below $55 a share: CNBC

NEW YORK Carson Block, the head of short-selling firm Muddy Waters, said on Friday that shares of medical device maker St. Jude Medical Inc could fall to $55 per share or lower if Abbott Laboratories' deal to buy the company falls apart.

27 Aug 2016

UPDATE 2-St. Jude says report by short sellers 'false and misleading'

Aug 26 Medical device manufacturer St. Jude Medical Inc said on Friday that a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading."

27 Aug 2016

St. Jude says report by short sellers 'false and misleading'

Aug 26 Medical device manufacturer St. Jude Medical Inc said on Friday that a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading."

27 Aug 2016

St. Jude stock shorted on heart device hacking fears; shares drop

The stock of pacemaker manufacturer St. Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall, claiming its implanted heart devices were vulnerable to cyber attacks. | Video

26 Aug 2016

UPDATE 3-Abbott sales beat on higher demand for medical devices

* Shares up 2.3 pct (Adds details about St. Jude, Alere acquisitions and share move)

20 Jul 2016

BRIEF-St Jude Medical reports Q2 earnings per share $0.83

* Total crm sales were $395 million for q2 of 2016, an 8 percent decline compared with Q2 of 2015

20 Jul 2016

Earnings vs. Estimates